These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 38151399

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immune checkpoint inhibitors and adrenal insufficiency: a large-sample case series study.
    Cui K, Wang Z, Zhang Q, Zhang X.
    Ann Transl Med; 2022 Mar; 10(5):251. PubMed ID: 35402601
    [Abstract] [Full Text] [Related]

  • 8. Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints.
    Chang LS, Barroso-Sousa R, Tolaney SM, Hodi FS, Kaiser UB, Min L.
    Endocr Rev; 2019 Feb 01; 40(1):17-65. PubMed ID: 30184160
    [Abstract] [Full Text] [Related]

  • 9. Hypophysitis and Secondary Adrenal Insufficiency From Immune Checkpoint Inhibitors: Diagnostic Challenges and Link With Survival.
    Johnson J, Goldner W, Abdallah D, Qiu F, Ganti AK, Kotwal A.
    J Natl Compr Canc Netw; 2023 Feb 24; 21(3):281-287. PubMed ID: 36828029
    [Abstract] [Full Text] [Related]

  • 10. Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage?
    Michot JM, Lazarovici J, Tieu A, Champiat S, Voisin AL, Ebbo M, Godeau B, Michel M, Ribrag V, Lambotte O.
    Eur J Cancer; 2019 Nov 24; 122():72-90. PubMed ID: 31634647
    [Abstract] [Full Text] [Related]

  • 11. Major Adverse Cardiac Events With Immune Checkpoint Inhibitors: A Pooled Analysis of Trials Sponsored by the National Cancer Institute-Cancer Therapy Evaluation Program.
    Naqash AR, Moey MYY, Cherie Tan XW, Laharwal M, Hill V, Moka N, Finnigan S, Murray J, Johnson DB, Moslehi JJ, Sharon E.
    J Clin Oncol; 2022 Oct 10; 40(29):3439-3452. PubMed ID: 35658474
    [Abstract] [Full Text] [Related]

  • 12. Immune-related adverse events in various organs caused by immune checkpoint inhibitors.
    Okiyama N, Tanaka R.
    Allergol Int; 2022 Apr 10; 71(2):169-178. PubMed ID: 35101349
    [Abstract] [Full Text] [Related]

  • 13. Endocrine immune-related adverse events in patients with metastatic renal and urothelial cancer treated with immune checkpoint-inhibitors.
    Oppolzer IA, Riester J, Büttner R, Burger M, Schnabel MJ.
    Int Urol Nephrol; 2023 Aug 10; 55(8):1943-1949. PubMed ID: 37271776
    [Abstract] [Full Text] [Related]

  • 14. Factors affecting tumor responders and predictive biomarkers of toxicities in cancer patients treated with immune checkpoint inhibitors.
    Yao L, Jia G, Lu L, Bao Y, Ma W.
    Int Immunopharmacol; 2020 Aug 10; 85():106628. PubMed ID: 32474388
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic and therapeutic approach to pulmonary infiltrates in cancer patients receiving immune checkpoint inhibitors.
    Fernández-Ruiz M.
    Rev Esp Quimioter; 2022 Oct 10; 35 Suppl 3(Suppl 3):67-73. PubMed ID: 36285862
    [Abstract] [Full Text] [Related]

  • 16. Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis.
    Barroso-Sousa R, Barry WT, Garrido-Castro AC, Hodi FS, Min L, Krop IE, Tolaney SM.
    JAMA Oncol; 2018 Feb 01; 4(2):173-182. PubMed ID: 28973656
    [Abstract] [Full Text] [Related]

  • 17. Risk of Ophthalmic Adverse Events in Patients Treated with Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis.
    Hou YL, Wang DY, Hu JX, Tian RY, Wang W, Su Q, Li H, Wang YL.
    Ocul Immunol Inflamm; 2022 Aug 01; 30(6):1449-1459. PubMed ID: 33970759
    [Abstract] [Full Text] [Related]

  • 18. Recent advances in immune checkpoint inhibitor-induced type 1 diabetes mellitus.
    Liao D, Liu C, Chen S, Liu F, Li W, Shangguan D, Shi Y.
    Int Immunopharmacol; 2023 Sep 01; 122():110414. PubMed ID: 37390646
    [Abstract] [Full Text] [Related]

  • 19. Endocrine immune-related adverse effects of immune-checkpoint inhibitors.
    Trevisani V, Iughetti L, Lucaccioni L, Predieri B.
    Expert Rev Endocrinol Metab; 2023 Sep 01; 18(5):441-451. PubMed ID: 37682107
    [Abstract] [Full Text] [Related]

  • 20. A Systematic Review and Meta-Analysis of Endocrine-Related Adverse Events Associated with Immune Checkpoint Inhibitors.
    de Filette J, Andreescu CE, Cools F, Bravenboer B, Velkeniers B.
    Horm Metab Res; 2019 Mar 01; 51(3):145-156. PubMed ID: 30861560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.